PharmaCyte Biotech, Inc. (PMCB): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2013-04-30, while the company's latest annual report covers the year ended 2026-04-30. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$1.68M
Year ended 2013-04-30
2012-04-30: -$1.92M2013-04-30: -$1.68M-$1.68M
2012-04-30 EBITDA (USD) 2013-04-30
Period endedEBITDAChange YoYSource filing
2013-04-30-$1.68Mn/m2016-01-19, From 2012-05-01
2012-04-30-$1.92Mn/a2013-07-29, From 2011-05-01